Latest Share Chat

REMOVE ADS

Rentokil Initial Share News (RTO)

Rentokil Initial Information

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes

Get Live Data

429.30 0.30 (0.07%)

Bid:

428.60

Ask:

428.90

Spread: 0.30 (0.07%)

Market Cap: £10.80b

Last checked at -

Intraday Rentokil Initial Share Chart

REMOVE ADS

Rentokil Initial News

LONDON MARKET CLOSE: FTSE 100 flat as buyback boosts Imperial Brands

(Alliance News) - The FTSE 100 ended little changed on Tuesday, holding near recent record highs, supported by well received updates from Shell and Im...

Bernstein double upgrades Rentokil to 'outperform', hikes price target

(Sharecast News) - Bernstein doubled upgraded Rentokil Initial on Tuesday to 'outperform' from 'underperform' and hiked the price target to 570p from ...

LONDON MARKET CLOSE: Tesco delivers but FTSE ends 4-day winning run

(Alliance News) - Blue chips snapped a 4-day hot streak in London on Thursday, despite strong gains by Tesco, but remained in touching distance of Wed...

LONDON MARKET CLOSE: FTSE 100 hits new high despite US shutdown worry

(Alliance News) - The FTSE 100 ended the quarter with a flourish, hitting an all time high on Tuesday, as hopes grew of a peace settlement in the Midd...

LONDON MARKET MIDDAY: FTSE 100 higher despite US shutdown fears

(Alliance News) - Stock prices in London edged higher at midday in London, shaking off early losses and the threat of a US government shutdown, as inv...

Berenberg starts Rentokil at 'sell', points to challenges with Terminix integration

(Sharecast News) - Berenberg initiated coverage on Rentokil Initial on Monday with a 'sell' rating and 284p price target.

LONDON BROKER RATINGS: Jefferies ups Admiral and cuts Sabre Insurance

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

LONDON BRIEFING: AstraZeneca plans listing changes; GSK names next CEO

(Alliance News) - AstraZeneca plans changes to its US listing and to retain its position in London, GSK promotes its chief commercial officer to lead ...